DexCom Misled Investors About Its Diabetes Tech, Suit Says
Medical device maker DexCom is facing a proposed investor class action in聽Manhattan federal court alleging the company hurt shareholders by failing to disclose changes to a glucose monitoring device affecting the...To view the full article, register now.
Already a subscriber? Click here to view full article